Comparison of ultrasound-guided subacromial corticosteroid and ozone (O2-O3 ) injections in the treatment of chronic rotator cuff tendinopathy:a randomized clinical trial
- Author:
Merve Örücü ATAR
1
;
Nurdan KORKMAZ
;
Sefa Gümrük ASLAN
;
Özge TEZEN
;
Sinem Uyar KÖYLÜ
;
Yasin DEMIR
;
Serdar KESIKBURUN
Author Information
- Publication Type:Clinical Research Article
- From:The Korean Journal of Pain 2023;36(1):128-136
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:The authors aimed to compare the effects of a one-time ultrasound (US)-guided subacromial corticosteroid injection and three-time ozone (O2-O3 ) injection in patients with chronic supraspinatus tendinopathy.
Methods:Participants were randomly assigned to the corticosteroid group (n = 22) or ozone group (n = 22). Injections in both groups were administered into subacromial bursa with an US-guided in-plane posterolateral approach. Primary outcome measure was the change in the Western Ontario Rotator Cuff Index (WORC) score between baseline and 12-weeks post-injection. Secondary outcome measures included visual analog scale and Shoulder Pain and Disability Index scores. Assessments were recorded at baseline, and 4-weeks and 12-weeks post-injection.
Results:Forty participants completed this study. Based on repeated measurement analysis of variance, a significant effect of time was found for all outcome measures in both groups. Both the groups showed clinically significant improvements in shoulder pain, quality of life, and function. Baseline, 4-week post-injection, and 12-week post-injection WORC scores (mean ± standard deviation) were 57.91 ± 18.97, 39.10 ± 20.50 and 37.22 ± 27.31 in the corticosteroid group, respectively and 69.03 ± 15.89, 39.11 ± 24.36, and 32.26 ± 24.58 in the ozone group, respectively. However, no significant group × time interaction was identified regarding all outcome measures.
Conclusions:Three-time ozone injection was not superior to a one-time corticosteroid injection in patients with chronic supraspinatus tendinopathy. It might be as effective as corticosteroid injection at 4-weeks and 12-weeks post-injection in terms of relieving pain and improving quality of life and function.
